Bookmark
Forward
QuickView for Isotretinoin (compound)
PubChem
| Name: | Isotretinoin |
|---|---|
| PubChem Compound ID: | 5282379 |
| Description: | A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. |
| Molecular formula: | C20H28O2 |
| Molecular weight: | 300.435 g/mol |
| Synonyms: |
BRN 1885770; EINECS 225-296-0; 4759-48-2; HSDB 3929; Isotretinoin [USAN:BAN:INN]; Retinoic acid, cis-; Isotretinoine [INN-French]; Ro-4-3780; Ro-43780; 13-cis-Vitamin A acid.
show more » |
DrugBank
Identification
| Name: | Isotretinoin |
|---|---|
| Name (isomeric): | DB00982 |
| Drug Type: | small molecule |
| Description: | A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. |
| Brand: | Accutane Roche |
| Category: | Keratolytic Agents, Antineoplastic Agents, Skin and Mucous Membrane Agents, Anti-acne Agents |
| CAS number: | 4759-48-2 |
Pharmacology
| Indication: | For the treatment of severe recalcitrant nodular acne |
|---|---|
| Pharmacology: |
Isotretinoin, a retinoid, is indicated in the treatment of severe recalcitrant nodular acne. Nodules are inflammatory lesions with a diameter of 5 mm or greater. The nodules may become suppurative or hemorrhagic. "Severe," by definition, means "many" as opposed to "few or several" nodules. Clinical improvement in nodular acne patients occurs in ass...
show more » |
| Mechanism of Action: | Isotretinoin noticeably reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones from forming. It also reduces inflammation in moderate-severe inflammatory acne. The exact mechanism of action is unknown, however it is known that it alters DNA transcription. |
| Protein binding: | 99.9% |
| Route of elimination: | Isotretinoin and its metabolites are further metabolized into conjugates, which are then excreted in urine and feces. The metabolites of isotretinoin and any conjugates are ultimately excreted in the feces and urine in relatively equal amounts (total of 65% to 83%). |
| Half Life: | 17-50 hours |
| Clearance: | 96 +/- 6.27 L/hr [severe recalcitrant nodular acne pediatric Patients, 12 to 15 Years] |
| Toxicity: | Isotretinoin is teratogenic. It also causes mucocutaneous side effects suck as cheilitis, dry skin, and dry eyes. |
| Affected organisms: | Humans and other mammals |
Interactions
| Food interaction: |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug interaction: |
|
Targets
